| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.BIOCEL.2007.07.013 |
| P698 | PubMed publication ID | 17804276 |
| P50 | author | Colin L. Masters | Q1108510 |
| Anthony R. White | Q38328317 | ||
| Ashley I. Bush | Q39880503 | ||
| Peter J. Crouch | Q48215086 | ||
| Susan-Marie E Harding | Q60743271 | ||
| James Camakaris | Q117233544 | ||
| P2860 | cites work | A specific amyloid-beta protein assembly in the brain impairs memory | Q28854597 |
| P433 | issue | 2 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| neurodegeneration | Q1755122 | ||
| P304 | page(s) | 181-198 | |
| P577 | publication date | 2007-08-01 | |
| P1433 | published in | International Journal of Biochemistry & Cell Biology | Q6051320 |
| P1476 | title | Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease | |
| P478 | volume | 40 |
| Q38836535 | A novel antagonistic role of natural compound icariin on neurotoxicity of amyloid β peptide |
| Q34079353 | A peptide that binds specifically to the β-amyloid of Alzheimer's disease: selection and assessment of anti-β-amyloid neurotoxic effects |
| Q33815126 | A prochelator activated by beta-secretase inhibits Abeta aggregation and suppresses copper-induced reactive oxygen species formation |
| Q36478423 | Advances in the pathogenesis of Alzheimer's disease: a re-evaluation of amyloid cascade hypothesis |
| Q38532705 | Alzheimer's Disease, Drosophila melanogaster and Polyphenols. |
| Q34849544 | Amyloid beta-protein assembly and Alzheimer disease |
| Q96438340 | Amyloid-β Oligomerization Monitored by Single-Molecule Stepwise Photobleaching |
| Q40760450 | Amyloid-β peptide-induced cytotoxicity and mitochondrial dysfunction in yeast. |
| Q41671303 | An N-heterocyclic amine chelate capable of antioxidant capacity and amyloid disaggregation |
| Q34800195 | An overview on the correlation of neurological disorders with cardiovascular disease |
| Q38716042 | Analysis of Epidermal Growth Factor Receptor Related Gene Expression Changes in a Cellular and Animal Model of Parkinson's Disease. |
| Q43132150 | Arginine metabolising enzymes as therapeutic tools for Alzheimer's disease: peptidyl arginine deiminase catalyses fibrillogenesis of beta-amyloid peptides |
| Q92219960 | Artemether Activation of AMPK/GSK3β(ser9)/Nrf2 Signaling Confers Neuroprotection towards β-Amyloid-Induced Neurotoxicity in 3xTg Alzheimer's Mouse Model |
| Q38120669 | BACE1 as a therapeutic target in Alzheimer's disease: rationale and current status |
| Q36150783 | Binding of β-amyloid (1-42) peptide to negatively charged phospholipid membranes in the liquid-ordered state: modeling and experimental studies |
| Q34104938 | Catalytic antioxidants and neurodegeneration |
| Q44106600 | Copper-β-amyloid peptides exhibit neither monooxygenase nor superoxide dismutase activities |
| Q34082529 | Design, synthesis, and biological evaluation of novel fluorinated ethanolamines. |
| Q34012473 | Despite its role in assembly, methionine 35 is not necessary for amyloid beta-protein toxicity |
| Q91705019 | Deterioration of cognitive function after transient cerebral ischemia with amyloid-β infusion-possible amelioration of cognitive function by AT2 receptor activation |
| Q39316774 | Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways |
| Q53443307 | Direct observation of internalization and ROS generation of amyloid β-peptide in neuronal cells at subcellular resolution. |
| Q28476715 | Direct observation of single amyloid-β(1-40) oligomers on live cells: binding and growth at physiological concentrations |
| Q33642530 | Effects of 4-hydroxy-nonenal and Amyloid-beta on expression and activity of endothelin converting enzyme and insulin degrading enzyme in SH-SY5Y cells |
| Q37219722 | Effects of HNE-modification induced by Abeta on neprilysin expression and activity in SH-SY5Y cells |
| Q30827278 | Gender-Specific Hippocampal Dysrhythmia and Aberrant Hippocampal and Cortical Excitability in the APPswePS1dE9 Model of Alzheimer's Disease |
| Q46514631 | Genetic ablation of the p66Shc adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer's disease. |
| Q89478137 | Glycogen synthase kinase-3 signaling in Alzheimer's disease |
| Q37883104 | Glycogen synthase kinase-3β: a mediator of inflammation in Alzheimer's disease? |
| Q58729326 | Importance of GPCR-Mediated Microglial Activation in Alzheimer's Disease |
| Q91632564 | Improving Cell Penetration of Gold Nanorods by Using an Amphipathic Arginine Rich Peptide |
| Q91272322 | In vitro study of interaction of 17β-hydroxysteroid dehydrogenase type 10 and cyclophilin D and its potential implications for Alzheimer's disease |
| Q37061979 | Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation |
| Q37969262 | Interaction between pathogenic proteins in neurodegenerative disorders |
| Q37364086 | Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease |
| Q48658737 | Intraneuronally injected amyloid β inhibits long-term potentiation in rat hippocampal slices |
| Q36197639 | Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester |
| Q92931996 | Metal Binding to Aβ Peptides Inhibits Interaction with Cytochrome c: Insights from Abiological Constructs |
| Q37957126 | Metal attenuating therapies in neurodegenerative disease |
| Q38242383 | Microglial Aβ receptors in Alzheimer's disease. |
| Q26801929 | Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease |
| Q57168757 | Mitochondrial accumulation of amyloid β (Aβ) peptides requires TOMM22 as a main Aβ receptor in yeast |
| Q27009475 | Mitochondrial dysfunction: different routes to Alzheimer's disease therapy |
| Q36391328 | Monitoring β-secretase activity in living cells with a membrane-anchored FRET probe |
| Q53143766 | Morphology-Specific Inhibition of β-Amyloid Aggregates by 17β-Hydroxysteroid Dehydrogenase Type 10. |
| Q36245638 | Motor Cortex Theta and Gamma Architecture in Young Adult APPswePS1dE9 Alzheimer Mice |
| Q34581928 | N-acetylcysteine prevents 4-hydroxynonenal- and amyloid-beta-induced modification and inactivation of neprilysin in SH-SY5Y cells |
| Q35687039 | Neuronal and vascular oxidative stress in Alzheimer's disease |
| Q45965330 | Neuroprotection of soyabean isoflavone co-administration with folic acid against beta-amyloid 1-40-induced neurotoxicity in rats. |
| Q40911238 | Nicotine contributes to the neural stem cells fate against toxicity of microglial-derived factors induced by Aβ via the Wnt/β-catenin pathway |
| Q53306103 | Nutritional status of selenium in Alzheimer's disease patients. |
| Q87512835 | Oxidative stress in Alzheimer's disease |
| Q33506441 | Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment |
| Q47105295 | Peripheral biomarkers of oxidative stress in aging and Alzheimer's disease |
| Q37295067 | Pharmacotherapeutic targets in Alzheimer's disease |
| Q48873344 | Possible role of metal ionophore against zinc induced cognitive dysfunction in D-galactose senescent mice |
| Q37581070 | Precise assembly and regulation of 26S proteasome and correlation between proteasome dysfunction and neurodegenerative diseases |
| Q37882078 | Protein aggregate spreading in neurodegenerative diseases: problems and perspectives |
| Q39578938 | Proteomic study of the toxic effect of oligomeric Aβ1-42 in situ prepared from 'iso-Aβ1-42'. |
| Q38871039 | Real-time investigation of cytochrome c release profiles in living neuronal cells undergoing amyloid beta oligomer-induced apoptosis |
| Q37187966 | Reassessing the amyloid cascade hypothesis of Alzheimer's disease |
| Q34999535 | Recent advances in our understanding of neurodegeneration |
| Q37316130 | Role of copper and cholesterol association in the neurodegenerative process |
| Q38782180 | Similarities and interactions between the ageing process and high chronic intake of added sugars |
| Q36621979 | Single-molecule imaging reveals aβ42:aβ40 ratio-dependent oligomer growth on neuronal processes |
| Q34235168 | Somatostatin modulates insulin-degrading-enzyme metabolism: implications for the regulation of microglia activity in AD |
| Q47952421 | Structural and functional insights into the anti-BACE1 Fab fragment that recognizes the BACE1 exosite |
| Q27010584 | Structural evolution and membrane interactions of Alzheimer's amyloid-beta peptide oligomers: new knowledge from single-molecule fluorescence studies |
| Q41910331 | Structural studies of copper(I) complexes of amyloid-beta peptide fragments: formation of two-coordinate bis(histidine) complexes |
| Q35162996 | Substantial contribution of the two imidazole rings of the His13-His14 dyad to Cu(II) binding in amyloid-β(1-16) at physiological pH and its significance. |
| Q92936204 | Tailoring Hydrophobic Interactions between Probes and Amyloid-β Peptides for Fluorescent Monitoring of Amyloid-β Aggregation |
| Q37883102 | Targeting Glycogen Synthase Kinase-3β for Therapeutic Benefit against Oxidative Stress in Alzheimer's Disease: Involvement of the Nrf2-ARE Pathway. |
| Q39499173 | The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity |
| Q37696521 | The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease |
| Q27015793 | The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology |
| Q36899891 | The structure of the amyloid-beta peptide high-affinity copper II binding site in Alzheimer disease |
| Q37866222 | The use of mass spectrometry to study amyloid-β peptides. |
| Q34548586 | Toll-like receptors in Alzheimer's disease |
| Q40009615 | Transthyretin binding to A-Beta peptide--impact on A-Beta fibrillogenesis and toxicity. |
| Q37960498 | Utilization of APPswe/PS1dE9 Transgenic Mice in Research of Alzheimer's Disease: Focus on Gene Therapy and Cell-Based Therapy Applications |
| Q33757597 | Xanthoceraside ameliorates mitochondrial dysfunction contributing to the improvement of learning and memory impairment in mice with intracerebroventricular injection of aβ1-42. |
Search more.